Emtricitabine/tenofovir alafenamide and doravirine in a virologically suppressed adult with HIV and on chronic ambulatory peritoneal dialysis: A case report.
| Autor: | Bickenbach E; Department of Pharmacy, Novant Health New Hanover Regional Medical Center, Wilmington, NC, USA., Pan J; Department of Internal Medicine, Novant Health New Hanover Regional Medical Center, Wilmington, NC, USA., King M; Department of Pharmacy, Novant Health New Hanover Regional Medical Center, Wilmington, NC, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of STD & AIDS [Int J STD AIDS] 2024 Sep; Vol. 35 (10), pp. 828-830. Date of Electronic Publication: 2024 Jun 11. |
| DOI: | 10.1177/09564624241259516 |
| Abstrakt: | Data supporting the safe and effective use of first-line antiretroviral therapy in people living with HIV on hemodialysis or peritoneal dialysis remains limited. Previously in this journal, the first case report of BIC/FTC/TAF use in chronic ambulatory peritoneal dialysis was presented. We present the first known case of DOR + FTC/TAF in chronic ambulatory peritoneal dialysis. Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|